ERBB2 and neoplasm: Multiple studies have demonstrated that the intensity of FDG uptake is associated with aggressiveness and prognostic factors of breast cancer, such as larger tumor size, high histologic grade, hormone receptor negativity, triple negativity, HER2 overexpression, and axillary lymph node (LN) metastasis15–17.